The management team and Board of Directors acquired an additional unknown minority stake in MediPharm Labs Corp. (TSXV:LABS) effective January 9, 2019. Under the transaction, MediPharm Labs Board of Directors and management team have increased aggregate shareholdings following the exercise of 5.45 million options. As a result of the transaction, the total shareholding in MediPharm Labs increased to 39%.